EMERGENT BIOSOLUTIONS INC. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$171M
Free Cash Flow
$157M
Investing Cash Flow
$69M
Financing Cash Flow
$-137M
Capex
$14M
Acquisitions
—
Stock Buybacks
$25M
Stock-Based Comp
$16M
Debt Issued
—
Debt Repaid
—
D&A
$96M
SBC Allocated Expense
$16M